Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc.

ORKA
Oruka Therapeutics, Inc.US flagNASDAQ Global Market
94.32
USD
+2.61
- -
3.53BMarket Cap

Oruka Therapeutics, Inc. (ORKA) Stock Split History

Learn about Oruka Therapeutics, Inc.'s most recent 1-for-12 basis stock split on September 03, 2024. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Oruka Therapeutics, Inc.'s most recent stock split

Split Date: 2024-09-03
Split Ratio: 1:12
Price Before Split: $2.13
Price After Split: $0.18

Developer API

Get ORKA split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/ORKA

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 12.00 times fewer shares (a 1:12 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Oruka Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2024-09-031:12Yes$2.13$0.18
2019-04-041:18Yes$0.31$0.02
2015-09-041:7Yes$0.91$0.13
2013-03-051:6Yes$0.43$0.07
2009-01-281:20Yes$0.22$0.01
2004-02-231:3Yes$4.35$1.45

About Oruka Therapeutics, Inc.

Company overview and industry information

Oruka Therapeutics, Inc. (ORKA) operates in the Biotechnology industry. The recent 1-for-12 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Oruka Therapeutics, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.